Kazuaki Sasaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kazuaki Sasaki has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Mohamed Elbadawy
Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Japan
4 shared publications Kimika Hayashi
Dept. Vet Med., Fac. agr., Tokyo Univ of Agr and Tech
3 shared publicationsMegumi Yamanaka
Dept. Vet Med., Fac. agr., Tokyo Univ of Agr and Tech
3 shared publications- Tatsuya Usui
Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Japan
3 shared publications Yuta Shinohara
Dept. Vet Med., Fac. agr., Tokyo Univ of Agr and Tech
3 shared publications- Amira Abugomaa
Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509, Japan
2 shared publications
Latest Publications
- 1 December 2022
- Published by Springer Nature in Veterinary Research Communications
- Vol. 47 (2) , 849-859
Effect of xylazine sedation on testicular blood flow, testicular echotexture, and circulating hormones in Shiba goats
- 1 December 2022
- Published by Springer Nature in Veterinary Research Communications
- Vol. 47 (2) , 849-859
Effect of xylazine sedation on testicular blood flow, testicular echotexture, and circulating hormones in Shiba goats
- Open Access
- 1 January 2021
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 94, 1-P2
Study of Anti-proliferative Effects of Chaga Mushroom and Panax Notoginseng-containing Traditional Chinese Medical Supplement, Shibe-ria on Dog Bladder Cancer Stem Cells
【Background】Since the malignancy of dog bladder cancer (BC) is higher than human BC, most BC bearing dogs die early. In our laboratory, we established the method of bladder cancer organoid culture using the cancer stem cells in their urine samples. On the one hand, the usage of traditional Chinese medicine has been increasing in veterinary medicine. In our laboratory, we treated dog BC organoids with 39 kinds of traditional Chinese medicines. Among them, we clarified anti-proliferative effects of Chaga mushroom and Panax notoginseng-containing traditional Chinese medical supplement, Shibe-ria on dog BC stem cells. 【Object】This study aimed to clarify anti-proliferative mechanisms and components of Shibe-ria on dog BC organoids.【Methods and Results】Dog BC organoids were treated with Shibe-ria (100 μg/ml) for 6-24 hours and the expression of cancer stem cell markers was evaluated using Real time PCR. The expression of CD44 and SOX2 mRNA was significantly reduced. On the one hand, Dog BC organoids were treated with Shibe-ria extracted by various solvents (50-100 μg/ml) for 72 hours, respectively. The cell viability of the organoids was assessed by Alamarblue assay. Shibe-ria extracted by 20 %, 50 %, 70 % methanol suppressed cell viability of dog BC organoids. 【Discussion】We for the first time demonstrated that Shibe-ria inhibited the proliferation of dog BC organoids by suppressing expression of CD44 and SOX2 mRNA. Components in Shibe-ria extracted by 20 %, 50 %, 70 % methanol were suggested to inhibit the proliferation of dog BC organoids.
- 1 January 2021
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 94, 1-P2
Open AccessStudy of Anti-proliferative Effects of Chaga Mushroom and Panax Notoginseng-containing Traditional Chinese Medical Supplement, Shibe-ria on Dog Bladder Cancer Stem Cells
【Background】Since the malignancy of dog bladder cancer (BC) is higher than human BC, most BC bearing dogs die early. In our laboratory, we established the method of bladder cancer organoid culture using the cancer stem cells in their urine samples. On the one hand, the usage of traditional Chinese medicine has been increasing in veterinary medicine. In our laboratory, we treated dog BC organoids with 39 kinds of traditional Chinese medicines. Among them, we clarified anti-proliferative effects of Chaga mushroom and Panax notoginseng-containing traditional Chinese medical supplement, Shibe-ria on dog BC stem cells. 【Object】This study aimed to clarify anti-proliferative mechanisms and components of Shibe-ria on dog BC organoids.【Methods and Results】Dog BC organoids were treated with Shibe-ria (100 μg/ml) for 6-24 hours and the expression of cancer stem cell markers was evaluated using Real time PCR. The expression of CD44 and SOX2 mRNA was significantly reduced. On the one hand, Dog BC organoids were treated with Shibe-ria extracted by various solvents (50-100 μg/ml) for 72 hours, respectively. The cell viability of the organoids was assessed by Alamarblue assay. Shibe-ria extracted by 20 %, 50 %, 70 % methanol suppressed cell viability of dog BC organoids. 【Discussion】We for the first time demonstrated that Shibe-ria inhibited the proliferation of dog BC organoids by suppressing expression of CD44 and SOX2 mRNA. Components in Shibe-ria extracted by 20 %, 50 %, 70 % methanol were suggested to inhibit the proliferation of dog BC organoids.
- Open Access
- 1 January 2020
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 93, 2-232
Elucidation of mechanism of growth inhibition of human colorectal stem cell by dietary polyphenol antioxidant.
【Background】Polyphenol compounds in foods contain antioxidants and are known to have effects of liver protection, hypoglycemic, and cholesterol-lowering. Colorectal cancer is one of the most types of cancers and the mortality rate is the second-highest in Japan. Since cancer stem cells are related to drug resistance and recurrence of colorectal cancer, a new remedy that targets cancer stem cells is needed. In the previous study, we established a novel culture method of the human colorectal air-liquid interface (ALI) organoids, which could recapitulate three-dimensional cancer microenvironment including patient-derived cancer stem cells. In this study, we investigated whether polyphenol antioxidants affect the survival rate of human colorectal ALI organoids and analyzed the inhibitory mechanisms.【Methods and results】Organoids were treated with polyphenol antioxidants at the dose of 3-100 μg/ml for 72 hours. The survival rate of organoids was measured by alamarblue assay. Polyphenol antioxidants suppressed survival rate of organoids in a concentration-dependent manner. The expression of marker genes for cancer stem cells, LGR5 and PROM1 were drastically decreased by polyphenol antioxidants. Expression of a G1/S transition-related gene, CCND1 was also decreased.【Conclusion】These results suggest that polyphenol antioxidants inhibit proliferation of human colorectal cancer stem cells via suppression of LGR5, PROM1, and CCND1, which might lead to the development of dietary supplements targeting colorectal cancer stem cells.
- 1 January 2020
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 93, 2-232
Open AccessElucidation of mechanism of growth inhibition of human colorectal stem cell by dietary polyphenol antioxidant.
【Background】Polyphenol compounds in foods contain antioxidants and are known to have effects of liver protection, hypoglycemic, and cholesterol-lowering. Colorectal cancer is one of the most types of cancers and the mortality rate is the second-highest in Japan. Since cancer stem cells are related to drug resistance and recurrence of colorectal cancer, a new remedy that targets cancer stem cells is needed. In the previous study, we established a novel culture method of the human colorectal air-liquid interface (ALI) organoids, which could recapitulate three-dimensional cancer microenvironment including patient-derived cancer stem cells. In this study, we investigated whether polyphenol antioxidants affect the survival rate of human colorectal ALI organoids and analyzed the inhibitory mechanisms.【Methods and results】Organoids were treated with polyphenol antioxidants at the dose of 3-100 μg/ml for 72 hours. The survival rate of organoids was measured by alamarblue assay. Polyphenol antioxidants suppressed survival rate of organoids in a concentration-dependent manner. The expression of marker genes for cancer stem cells, LGR5 and PROM1 were drastically decreased by polyphenol antioxidants. Expression of a G1/S transition-related gene, CCND1 was also decreased.【Conclusion】These results suggest that polyphenol antioxidants inhibit proliferation of human colorectal cancer stem cells via suppression of LGR5, PROM1, and CCND1, which might lead to the development of dietary supplements targeting colorectal cancer stem cells.
- Open Access
- 1 January 2020
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 93, 2-260
Study of Anti-proliferative Effects of Traditional Chinese Medicine and Crude Drug Extract on Dog Bladder Cancer Stem Cells
【Background】Since the malignancy of dog bladder cancer (BC) is higher than human BC, most BC bearing dogs die early. In our laboratory, we established the method of bladder cancer organoid culture using the cancer stem cells in their urine samples and demonstrated the organoids can be used for an anti-cancer drug sensitivity test. On the one hand, the usage of traditional Chinese medicine has been increasing in veterinary medicine. Although not a few veterinarians use traditional Chinese medicine for cancer, little is known about direct effects and detailed mechanisms of traditional Chinese medicine on dog cancer cells and cancer stem cells.【Object】The purpose of this study is to clarify the effects of traditional Chinese medicines on BC bearing dogs by examining the effects of several traditional Chinese medicines, traditional Chinese medical supplements and crude drug extracts using a dog BC organoid culture system.【Methods and Results】Dog BC organoids were treated with 39 kinds of traditional Chinese medicines, traditional Chinese medical supplements and crude drug extracts (10- 100 mg/ml) for 72 hours, respectively. The cell viability of the organoids was assessed by Alamarblue assay. Among these drugs and supplements, treatment of shibe-ria and ro-ka suppressed cell viability of dog BC organoids in a concentration-dependent manner. 【Discussion】We for the first time demonstrated that traditional Chinese medical supplements, shibe-ria and ro-ka had suppressive effects of dog BC stem cells.
- 1 January 2020
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 93, 2-260
Open AccessStudy of Anti-proliferative Effects of Traditional Chinese Medicine and Crude Drug Extract on Dog Bladder Cancer Stem Cells
【Background】Since the malignancy of dog bladder cancer (BC) is higher than human BC, most BC bearing dogs die early. In our laboratory, we established the method of bladder cancer organoid culture using the cancer stem cells in their urine samples and demonstrated the organoids can be used for an anti-cancer drug sensitivity test. On the one hand, the usage of traditional Chinese medicine has been increasing in veterinary medicine. Although not a few veterinarians use traditional Chinese medicine for cancer, little is known about direct effects and detailed mechanisms of traditional Chinese medicine on dog cancer cells and cancer stem cells.【Object】The purpose of this study is to clarify the effects of traditional Chinese medicines on BC bearing dogs by examining the effects of several traditional Chinese medicines, traditional Chinese medical supplements and crude drug extracts using a dog BC organoid culture system.【Methods and Results】Dog BC organoids were treated with 39 kinds of traditional Chinese medicines, traditional Chinese medical supplements and crude drug extracts (10- 100 mg/ml) for 72 hours, respectively. The cell viability of the organoids was assessed by Alamarblue assay. Among these drugs and supplements, treatment of shibe-ria and ro-ka suppressed cell viability of dog BC organoids in a concentration-dependent manner. 【Discussion】We for the first time demonstrated that traditional Chinese medical supplements, shibe-ria and ro-ka had suppressive effects of dog BC stem cells.
- Open Access
- 1 January 2015
- Published by Japanese Society of Veterinary Science in Journal of Veterinary Medical Science
- Vol. 77 (9) , 1171-1173
Effect of cyclosporin on distribution of methotrexate into the brain of rats
The effect of the antitumor drug, methotrexate (MTX), which is applied to brain tumors, is restricted by the blood-brain barrier (BBB), which is composed of P-glycoprotein (P-gp) and multidrug resistance associated protein (MRP). We, therefore, studied if a potent P-gp and MRP modulator, cyclosporin A (CysA), can modulate the MTX concentration in the rat brain. If it can, which route is more effective, intravenous or intrathecal? We intravenously or intrathecally administered MTX to rats with or without CysA. After 6 hr, brains and cerebrospinal fluid (CSF) were sampled, and their MTX concentrations were compared. Each MTX concentration was determined by high-performance liquid chromatography with UV detection. CysA had no significant affect on the MTX concentration in the brain or CSF when MTX was intravenously injected. In contrast, when MTX was intrathecally administered, CysA had a larger effect on the MTX concentration in the brain than in the CSF. This indicates CysA potentiated the brain MTX concentration when MTX was intrathecally administered. It is suggested that CysA did not potentiate the distribution of MTX from blood into the brain, but instead potentiated the distribution of MTX from CSF into the brain. Since chemicals in CSF generally diffuse into the brain easily, CysA probably inhibited the excretion of MTX from the brain. This could be caused by inhibition of P-gp or MRP at the BBB. Therefore, CysA can be a useful tool to achieve an appropriate MTX concentration in brain.
- 1 January 2015
- Published by Japanese Society of Veterinary Science in Journal of Veterinary Medical Science
- Vol. 77 (9) , 1171-1173
Open AccessEffect of cyclosporin on distribution of methotrexate into the brain of rats
The effect of the antitumor drug, methotrexate (MTX), which is applied to brain tumors, is restricted by the blood-brain barrier (BBB), which is composed of P-glycoprotein (P-gp) and multidrug resistance associated protein (MRP). We, therefore, studied if a potent P-gp and MRP modulator, cyclosporin A (CysA), can modulate the MTX concentration in the rat brain. If it can, which route is more effective, intravenous or intrathecal? We intravenously or intrathecally administered MTX to rats with or without CysA. After 6 hr, brains and cerebrospinal fluid (CSF) were sampled, and their MTX concentrations were compared. Each MTX concentration was determined by high-performance liquid chromatography with UV detection. CysA had no significant affect on the MTX concentration in the brain or CSF when MTX was intravenously injected. In contrast, when MTX was intrathecally administered, CysA had a larger effect on the MTX concentration in the brain than in the CSF. This indicates CysA potentiated the brain MTX concentration when MTX was intrathecally administered. It is suggested that CysA did not potentiate the distribution of MTX from blood into the brain, but instead potentiated the distribution of MTX from CSF into the brain. Since chemicals in CSF generally diffuse into the brain easily, CysA probably inhibited the excretion of MTX from the brain. This could be caused by inhibition of P-gp or MRP at the BBB. Therefore, CysA can be a useful tool to achieve an appropriate MTX concentration in brain.
- Open Access
- 1 January 2015
- Published by Japanese Society of Veterinary Science in Journal of Veterinary Medical Science
- Vol. 77 (1) , 21-26
Oral pharmacokinetics of the acidic drugs, diclofenac and sulfamonomethoxine in male Shiba goats
In the present study, we examined the oral pharmacokinetics of the acidic drugs, diclofenac (DF) and sulfamonomethoxine (SMM), which have different physicochemical properties, in Shiba goats. DF and SMM were intravenously and orally administered to 5 male goats using a crossover design. The T(max) of DF and SMM were reached 1.5 and 5.6 hr after they have been orally administered, respectively, and this was followed by their slow elimination. The elimination of both drugs was markedly faster after being intravenously rather than orally administered, which indicated flip-flop phenomena after the oral administration. The mean absorption times (MATs) of DF and SMM were 6 and 15 hr, respectively. This slow absorption may have been due to slow gastric emptying in goats. The large difference observed in MATs between DF and SMM may have been because DF, which is more lipophilic than SMM, was partly absorbed from the forestomach. Therefore, these results suggest that the absorption of highly lipophilic drugs from the forestomach may be markedly high in Shiba goats. In case of drugs whose elimination is quite fast, their efficacies may appear from the early stage after oral administration even in ruminants, because elimination rate is the determinant factor of T(max) in flip-flop phenomena. Such drugs may be used orally even in ruminants.
- 1 January 2015
- Published by Japanese Society of Veterinary Science in Journal of Veterinary Medical Science
- Vol. 77 (1) , 21-26
Open AccessOral pharmacokinetics of the acidic drugs, diclofenac and sulfamonomethoxine in male Shiba goats
In the present study, we examined the oral pharmacokinetics of the acidic drugs, diclofenac (DF) and sulfamonomethoxine (SMM), which have different physicochemical properties, in Shiba goats. DF and SMM were intravenously and orally administered to 5 male goats using a crossover design. The T(max) of DF and SMM were reached 1.5 and 5.6 hr after they have been orally administered, respectively, and this was followed by their slow elimination. The elimination of both drugs was markedly faster after being intravenously rather than orally administered, which indicated flip-flop phenomena after the oral administration. The mean absorption times (MATs) of DF and SMM were 6 and 15 hr, respectively. This slow absorption may have been due to slow gastric emptying in goats. The large difference observed in MATs between DF and SMM may have been because DF, which is more lipophilic than SMM, was partly absorbed from the forestomach. Therefore, these results suggest that the absorption of highly lipophilic drugs from the forestomach may be markedly high in Shiba goats. In case of drugs whose elimination is quite fast, their efficacies may appear from the early stage after oral administration even in ruminants, because elimination rate is the determinant factor of T(max) in flip-flop phenomena. Such drugs may be used orally even in ruminants.
- Open Access
- 1 January 2009
- Published by Japanese Society of Veterinary Science in Journal of Veterinary Medical Science
- Vol. 71 (9) , 1151-1159
Inhibitory Effects of Ketoconazole, Cimetidine and Erythromycin on Hepatic CYP3A Activities in Cats
Inhibitory effects of ketoconazole (KTZ), cimetidine (CIM), and erythromycin (ERY) were examined on CYP3A activities. Midazolam 1'- and 4-hydroxylation (MDZ1'H and MDZ4H) were used to determine CYP3A activities in hepatic microsomes obtained from cats (n=4). The results showed that, all the examined drugs inhibited the reactions in a noncompetitive manner. The inhibitory constants (Ki) of KTZ were 2.80 ± 0.70 and 115 ± 28 μM for MDZ1'H and MDZ4H, respectively. Those of CIM were 3.13 and 3.27 mM and of ERY were 3.14 and 6.41 mM for MDZ1'H and MDZ4H, respectively. Mechanism-based inhibition was also examined in this study. KTZ significantly reduced MDZ reactions in a time-dependent manner; while CIM and ERY did not. Also, the effects of KTZ and CIM on the pharmacokinetics of quinidine (QUN) were studied. KTZ or CIM (10 mg/kg/day, for one week) was given orally to cats (n=5). QUN (2 mg/kg, i. v.) was injected 2 hr after the last dose of KTZ or CIM. The analysis of the obtained pharmacokinetic parameters showed that, KTZ significantly reduced total body clearance of QUN by 35%, while CIM did not. These results suggest that, KTZ inhibits CYP3A activities (both in vitro and in vivo), but CIM does not. In clinical practice, therefore, KTZ may result in inhibition based drug-drug interaction with CYP3A substrates in cat patients, whereas CIM and ERY are unlikely to lead to interaction involving CYP3A substrates.
- 1 January 2009
- Published by Japanese Society of Veterinary Science in Journal of Veterinary Medical Science
- Vol. 71 (9) , 1151-1159
Open AccessInhibitory Effects of Ketoconazole, Cimetidine and Erythromycin on Hepatic CYP3A Activities in Cats
Inhibitory effects of ketoconazole (KTZ), cimetidine (CIM), and erythromycin (ERY) were examined on CYP3A activities. Midazolam 1'- and 4-hydroxylation (MDZ1'H and MDZ4H) were used to determine CYP3A activities in hepatic microsomes obtained from cats (n=4). The results showed that, all the examined drugs inhibited the reactions in a noncompetitive manner. The inhibitory constants (Ki) of KTZ were 2.80 ± 0.70 and 115 ± 28 μM for MDZ1'H and MDZ4H, respectively. Those of CIM were 3.13 and 3.27 mM and of ERY were 3.14 and 6.41 mM for MDZ1'H and MDZ4H, respectively. Mechanism-based inhibition was also examined in this study. KTZ significantly reduced MDZ reactions in a time-dependent manner; while CIM and ERY did not. Also, the effects of KTZ and CIM on the pharmacokinetics of quinidine (QUN) were studied. KTZ or CIM (10 mg/kg/day, for one week) was given orally to cats (n=5). QUN (2 mg/kg, i. v.) was injected 2 hr after the last dose of KTZ or CIM. The analysis of the obtained pharmacokinetic parameters showed that, KTZ significantly reduced total body clearance of QUN by 35%, while CIM did not. These results suggest that, KTZ inhibits CYP3A activities (both in vitro and in vivo), but CIM does not. In clinical practice, therefore, KTZ may result in inhibition based drug-drug interaction with CYP3A substrates in cat patients, whereas CIM and ERY are unlikely to lead to interaction involving CYP3A substrates.
- Open Access
- 1 September 2004
- Published by Wiley in Cancer Science
- Vol. 95 (9) , 765-769
Sonodynamic therapy on chemically induced mammary tumor: Pharmacokinetics, tissue distribution and sonodynamically induced antitumor effect of porfimer sodium
The sonodynamically induced antitumor effect of porfimer sodium (PF) was evaluated on a chemically induced mammary tumor in Sprague‐Dawley rats. The timing of 24 h after the administration of PF was chosen for the ultrasonic exposure, based on pharmacokinetic analysis of the PF concentrations in the tumor, plasma, skin and muscle. At a PF dose not less than 2.5 mg/kg and at a free‐field ultrasonic intensity not less than 3 W/cm2, the synergistic effect between PF administration and ultrasonic exposure on the tumor growth inhibition was significant. The ultrasonic intensity showed a relatively sharp threshold for the synergistic antitumor effect, which is typical of an ultrasonic effect mediated by acoustic cavitation. These results suggest that PF is a potentially useful as a sonosensitizer for sonodynamic treatment of chemically induced tumors.
- 1 September 2004
- Published by Wiley in Cancer Science
- Vol. 95 (9) , 765-769
Open AccessSonodynamic therapy on chemically induced mammary tumor: Pharmacokinetics, tissue distribution and sonodynamically induced antitumor effect of porfimer sodium
The sonodynamically induced antitumor effect of porfimer sodium (PF) was evaluated on a chemically induced mammary tumor in Sprague‐Dawley rats. The timing of 24 h after the administration of PF was chosen for the ultrasonic exposure, based on pharmacokinetic analysis of the PF concentrations in the tumor, plasma, skin and muscle. At a PF dose not less than 2.5 mg/kg and at a free‐field ultrasonic intensity not less than 3 W/cm2, the synergistic effect between PF administration and ultrasonic exposure on the tumor growth inhibition was significant. The ultrasonic intensity showed a relatively sharp threshold for the synergistic antitumor effect, which is typical of an ultrasonic effect mediated by acoustic cavitation. These results suggest that PF is a potentially useful as a sonosensitizer for sonodynamic treatment of chemically induced tumors.
- 1 January 1993
- Published by Springer Nature
- p. 749-752
Contribution of Plasma Protein Binding to the Stability of Tetrahydrofolate in Pig Plasma
- 1 January 1993
- Published by Springer Nature
- p. 749-752
Contribution of Plasma Protein Binding to the Stability of Tetrahydrofolate in Pig Plasma